| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |